drugset
drugset / Trial / NCT07636928

Mass Balance and Absolute Oral Bioavailability of [14C]VH4524184

NCT07636928 ↗

Phase 1 Recruiting 9 enrolled ViiV Healthcare
NaSingle-groupOpen-labelBasic science

Summary

The purpose of the study is to assess the bioavailability, mass balance, pharmacokinetics, metabolism and excretion of radiolabeled (14C) VH4524184.

Timeline

Start
2026-06-04
Primary completion
2026-08-20
Completion
2026-08-20

Drugs

EvaluationDrugModalityDoseRoute
Subject VH4524184 Unknown — —

Indications

HIV infectious disease